Maria Belmonte (@MariaBelmonte95) header
Maria Belmonte (@MariaBelmonte95) profile picture

Radiation oncology ☢️ resident at Fondazione IRCCS San Gerardo dei Tintori 🇮🇹 @unimib.

Joined February 2023
Photo by Maria Belmonte (@MariaBelmonte95)
No Better way to start 2025 A great Pleasure to Present our paper on Management of patients with Advanced #ProstateCancer A Report from #APCCC24 LINK TO ARTICLE👇👇👇 sciencedirect.com/science/ar… The 2024 Advanced Prostate Cancer Consensus Conference (APCCC) highlights significant advances in prostate cancer management while underscoring areas where high-quality evidence is still lacking. The conference gathered expert opinions on controversial clinical issues, particularly in advanced prostate cancer, offering guidance in cases where guidelines are unclear or conflicting. The report emphasizes personalized treatment approaches, considering patient-specific factors and evolving clinical data, and stresses the importance of ongoing clinical trials to fill knowledge gaps. It provides a practical framework for physicians and patients to engage in shared decision-making, especially in complex cases of high-risk localized and locally advanced prostate cancer. Our Thanks to all authors: @Silke_Gillessen @fabioturco92 @Prof_IanD @drjefstathiou Karim Fizazi @Prof_Nick_James Neal Shore Eric Small Matthew Smith @ChrisSweens1 @BertrandTOMBAL @ZilliThomas @neerajaiims Emmanuel S. Antonarakis Ana Aparicio Andrew J. Armstrong Diogo Assed Bastos Gerhardt Attard Karol Axcrona Mouna Ayadi Himisha Beltran @bjartell @PBlanchardMD @BourlonMaite @Albert0Briganti Muhammad Bulbul Consuelo Buttigliero Orazio Caffo @cdanicas @Ecastromarcos Heather H. Cheng Kim N. Chi Caroline S. Clarke Noel Clarke Johann S. de Bono @mdesantis234 @nachoduranm @EfstathiouEleni Onyeanunam N. Ekeke Tamer I.H. El Nahas @drlouiseemmett @stefanofanti4 Omolara A. Fatiregun Felix Y. Feng Peter C.C. Fong @fontev1 @Nicola_Fossati Daniel J. George @marty_gleave Gwenaelle Gravis Susan Halabi Daniel Heinrich @ProfKHerrmann @DrMHofman Thomas A. Hope Lisa G. Horvath Maha H.A. Hussain @BarbaraJereczek Robert J. Jones Anthony M. Joshua @ravikanesvaran Daniel Keizman @FacsRaja Gero Kramer @LoebStacy Brandon A. Mahal Fernando C. Maluf , @quimmateo David Matheson, Mika P. Matikainen , Ray McDermott, @DrRanaMcKay Niven Mehra, @amerseburger @CaPsurvivorship Michael J. Morris , Hind Mrabti, Deborah Mukherji @declangmurphy Vedang Murthy Shingai B.A. Mutambirwa @DrPaulNguyen @WilliamOhMD @piet_ost Joe M. O’Sullivan Anwar R. Padhani Chris Parker Darren M.C. Poon Colin C. Pritchard Danny M Rabah Dana Rathkopf Robert E. Reiter Raphaele Renard-Penna Charles J. Ryan Fred Saad Juan Pablo Sade Shahneen Sandhu Oliver A. Sartor Edward Schaeffer Howard I. Scher Nima Sharifi Iwona A. Skoneczna Howard R. Soule @DrSpratticus Sandy Srinivas @cnsternberg Hiroyoshi Suzuki Mary-Ellen Taplin Camilla Thellenberg-Karlsson Derya Tilki Levent N. Türkeri Hiroji Uemur @DrYukselUrun Claire L. Vale Neha Vapiwala Jochen Walz Kosj Yamoah Dingwei Ye Evan Y. Yu Almudena Zapatero @AOmlin
2
58
2
158
19,454
🤙🏻 Excited and proud of presenting the #ABRUPT trial @ASTRO 🙏 to all 1️⃣-fraction believers who followed me in this fool and amazing project @CChissotti @Fefe_Ferrario @Raffa_Lucchini @MariaBelmonte95 @riccardo_ray @valefacc22 @PanizzaDenis
4
10
1
32
1,929
🎬 our paper on 1️⃣-shot⚡️RT for UIR and HR PCa is finally out on @IJROBP 👏kudos to the authors for the team effort! #ABRUPT @CChissotti @Fefe_Ferrario @Raffa_Lucchini @MariaBelmonte95 @riccardo_ray @valefacc22 @PanizzaDenis redjournal.org/article/S0360…
5
18
1
50
4,142
🌟 The 9th edition of TNM Classification for Lung Cancer 🫁   1, January, 2024 〜
6
204
12
466
83,592
💥Finally the results of our experience in managing uncomplicated painful bone metastases (BM) patients. Pain response (CR+PR): ✔️62% at 1 month ✔️60% at 3 months. 📌A multidisciplinary approach is paramount to provide a better care to BM patients.
4
4
16
4,461
Maria Belmonte retweeted
Replying to @AlbertoBossial
@AlbertoBossial on the role of RT in MHSPC, discussing Stampede and Peace 1 results during #Prosca2023. @GETUG_Unicancer @OncoAlert @PCaParker – at Malaga, Spain
1
10
18
1,220
Throwback to Marseille #emuc2023. It was an honour and a pleasure to share the preliminary results of ABRUPT trial, single dose of 24 Gy on prostate gland is: ✅Feasible ✅Well tolerated A special thanks to my Professor @StAr_MCM74 and to my coworker and mentor @Raffa_Lucchini . – at Marseille, France
1
3
1
22
3,559
Friday night with @unimib ☢️residents in Monza! 💥 What a team!🤩🔝 @SofiaBianchi93 @martina_midulla @MiriamTorrisi @Fefe_Ferrario @CChissotti @MariaBelmonte95 @airo_young
3
26
1,535
The Lucerne Toolbox 2 to optimise axillary management for early #breastcancer : a multidisciplinary expert consensus Just published eClinicalMedicine! sciencedirect.com/science/ar… @OncoAlert #OncoAlert
16
20
2,526
What a day! Co-chair of #prostateSBRT session and interview by @Accuray #ESTRO2023 – at Vienna, Austria
1
1
22
1,621
IBA Proton therapy - Power up event @labstelle Wien ✨ It was a pleasure to meet you @LMU_Muenchen Belka Claus
2
12
969
Multidisciplinary approach is the key 🎯☢️💊🔪 #urooncology #iov
1
7
516
Maria Belmonte retweeted
36.25 Gy/5 fx linac-based prostate SBRT with 32.5 Gy urethra-sparing delivered every-other-day or once-a-week. Minimal impact on tox and QoL regardless of OTT: 5-yr G2+ GU and GI tox-free survival ~76% and ~90%; 5-yr bRFS >90% redjournal.org/article/S0360…
8
49
1
125
13,593